Challenges with QuantiFERON-TB gold assay for large-scale, routine screening of U.S. healthcare workers

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 8, 2013, Pages 1005-1010

  Slater, Madeline L ^a   Welland, Gary ^b   Pai, Madhukar ^c   Parsonnet, Julie ^a   Banaei, Niaz ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Healthcare workers; Interferon release assay; QuantiFERON; Reproducibility of results

Indexed keywords

GAMMA INTERFERON;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE PERSONNEL MANAGEMENT; HUMAN; LATENT TUBERCULOSIS; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTIFERON TUBERCULOSIS GOLD ASSAY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SCREENING TEST; TUBERCULIN TEST;

ADULT; FALSE POSITIVE REACTIONS; FEMALE; HEALTH PERSONNEL; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MASS SCREENING; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY; UNITED STATES;

EID: 84886437623     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201305-0831OC     Document Type: Article

References (31)

1. Jensen PA, Lambert LA, Iademarco MF, Ridzon R; CDC guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare settings, 2005. MMWR Recomm Rep 2005;54:1-141.
2. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep 2010;59:1-25.
3. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2012;67:62-70.
4. Ringshausen FC, Schablon A, Nienhaus A. Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review. J Occup Med Toxicol 2012;7:6.
5. CDC workplace safety and health topics. 2013 [accessed 2013 Mar 1]. Available from: www.cdc.gov/niosh/topics/healthcare/
6. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-354.
7. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177-184.
8. van Zyl-Smit RN, Zwerling A, Dheda K, Pai M.Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS ONE 2009;4:e8517.
9. Ringshausen FC, Nienhaus A, Torres Costa J, Knoop H, Schlösser S, Schultze-Werninghaus G, Rohde G. Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers. Clin Vaccine Immunol 2011;18:1176-1182.
10. Fong KS, Tomford JW, Teixeira L, Fraser TG, Vanduin D, Yen-Lieberman B, Gordon SM, Miranda C. Challenges of interferongamma release assay conversions in serial testing of health care workers in a tuberculosis control program. Chest 2012;142:55-62.
11. Yoshiyama T, Harada N, Higuchi K, Nakajima Y, Ogata H. Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-gamma assays. Epidemiol Infect 2009;137:1691-1698.
12. Torres Costa J, Silva R, Sá R, Cardoso MJ, Nienhaus A. Serial testing with the interferon-g release assay in Portuguese healthcare workers. Int Arch Occup Environ Health 2011;84:461-469.
13. Schablon A, Harling M, Diel R, Ringshausen FC, Torres Costa J, Nienhaus A. Serial testing with an interferon-gamma release assay in German healthcare workers. GMS Krankenhhyg Interdiszip 2010;5: Doc05.
14. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A; Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54:49-55.
15. Santa Clara County TB Cases Not Decreasing. 2011 [accessed 2013 Jun 20]. Available from: http://www.sccgov.org/sites/sccphd/en-us/Media/ Pages/TB-Cases.aspx
16. Larsen NM, Biddle CL, Sotir MJ, White N, Parrott P, Blumberg HM. Risk of tuberculin skin test conversion among health care workers: occupational versus community exposure and infection. Clin Infect Dis 2002;35:796-801.
17. Zwerling A, Benedetti A, Cojocariu M, McIntosh F, Pietrangelo F, Behr MA, Schwartzman K, Menzies D, Pai M. Repeat IGRA testing in Canadian health workers: conversions or unexplained variability? PLoS ONE 2013;8:e54748.
18. Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 2007;11:593-605.
19. Joshi M, Monson TP, Woods GL. Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States. Can Respir J 2012;19:84-88.
20. Belknap RPM, Wang Y, Dorman S, Graviss E, Weinfurter P, Daley C, Reves R. Re-running QuantiFERON-TB Gold In-Tube samples as a strategy for identifying false positive results [abstract]. Am J Respir Crit Care Med 2011;183:A1187.
21. Cellestis Limited. QuantiFERON-TB Gold In-Tube: package insert. Valencia, CA: Cellestis Limited. 2010 [accessed 2013 Apr 1]. Available from: http:// www.cellestis.com/irm/content/pdf/quantiferon%20us%20verg-jan2010% 20no%20trims.pdf
22. Thanassi W, Noda A, Hernandez B, Newell J, Terpeluk P, Marder D, Yesavage JA. Delineating a retesting zone using receiver operating characteristic analysis on serial QuantiFERON tuberculosis test results in US healthcare workers. Pulm Med 2012;2012:291-294.
23. Nienhaus A, Costa JT. Screening for tuberculosis and the use of a borderline zone for the interpretation of the interferon-g release assay (IGRA) in Portuguese healthcare workers. J Occup Med Toxicol 2013;8:1.
24. Doberne D, Gaur RL, Banaei N. Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection. J Clin Microbiol 2011;49:3061-3064.
25. Metcalfe JZ, Cattamanchi A, McCulloch CE, Lew JD, Ha NP, Graviss EA. Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med 2013;187:206-211.
26. Slater M, Parsonnet J, Banaei N. Investigation of false-positive results given by the QuantiFERON-TB Gold In-Tube assay. J ClinMicrobiol 2012;50:3105-3107.
27. Kik SV, Franken WP, Mensen M, Cobelens FG, Kamphorst M, Arend SM, Erkens C, Gebhard A, Borgdorff MW, Verver S. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 2010;35:1346-1353.
28. Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-g release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest 2012;142:63-75.
29. Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, Mwansa-Kambafwile J, Fielding K, Wilkinson RJ, Pai M. Predictive value of interferon-g release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:45-55.
30. Machingaidze S, Verver S, Mulenga H, Abrahams DA, Hatherill M, Hanekom W, Hussey GD, Mahomed H. Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents. Am J Respir Crit Care Med 2012;186:1051-1056.
31. Pai M, Kunimoto D, Jamieson F, Menzies D. Diagnosis of latent tuberculosis infection. Canadian TB Standards, 7th Edition. Can Respir J 2013;20(Suppl A):23A-34A.